Real-life data in 115 chronic migraine patients treated with Onabotulinumtoxin A during more than one year

BACKGROUND: OnabotulinumtoxinA (OnabotA) is effective in Chronic Migraine (CM) during first year of treatment and longer. In real clinical setting, CM patients with acute Medication Overuse (MO) or concurrently receiving oral preventatives are treated with OnabotA. We aim to assess evolution of CM p...

Descripción completa

Detalles Bibliográficos
Autores principales: Aicua-Rapun, I., Martínez-Velasco, E., Rojo, A., Hernando, A., Ruiz, M., Carreres, A., Porqueres, E., Herrero, S., Iglesias, F., Guerrero, A. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153399/
https://www.ncbi.nlm.nih.gov/pubmed/27957623
http://dx.doi.org/10.1186/s10194-016-0702-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153399/
https://www.ncbi.nlm.nih.gov/pubmed/27957623
http://dx.doi.org/10.1186/s10194-016-0702-1

Ejemplares similares